Open AccessIndirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients
Author(s) -
Adil Daud,
Japinder Gill,
S Kamra,
L. Chen,
Amit Ahuja
Publication year - 2017
Publication title -
onkologiâ
Language(s) - English
Resource type - Journals
eISSN - 2309-4745
pISSN - 2305-218X
DOI - 10.17116/onkolog20176335-43
Subject(s) - trametinib , vemurafenib , dabrafenib , metastatic melanoma , medicine , melanoma , mek inhibitor , cancer research , oncology , mapk/erk pathway , chemistry , phosphorylation , biochemistry